| Secondary |
| Product Used For Unknown Indication |
31.1% |
| Drug Use For Unknown Indication |
22.3% |
| Intentional Overdose |
13.6% |
| Psychotic Disorder |
11.7% |
| Completed Suicide |
6.8% |
| Depression |
1.9% |
| Diabetic Neuropathy |
1.9% |
| Emotional Distress |
1.9% |
| Neuralgia |
1.9% |
| Pneumonia Aspiration |
1.9% |
| Blood Cholesterol Increased |
1.0% |
| Diabetes Mellitus |
1.0% |
| Insomnia |
1.0% |
| Schizoaffective Disorder |
1.0% |
| Sleep Disorder |
1.0% |
|
| Suicide Attempt |
22.7% |
| Overdose |
9.1% |
| Rhabdomyolysis |
9.1% |
| Akathisia |
4.5% |
| Confusional State |
4.5% |
| Depression |
4.5% |
| Extrapyramidal Disorder |
4.5% |
| High Arched Palate |
4.5% |
| Intentional Overdose |
4.5% |
| Neuralgia |
4.5% |
| Pain In Extremity |
4.5% |
| Poor Quality Sleep |
4.5% |
| Somnolence |
4.5% |
| Suicidal Ideation |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Weight Increased |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.0% |
| Drug Use For Unknown Indication |
20.7% |
| Crohn's Disease |
6.9% |
| Insomnia |
6.9% |
| Pain |
5.9% |
| Hypertension |
5.1% |
| Depression |
3.3% |
| Diabetes Mellitus |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Analgesic Therapy |
2.6% |
| Bipolar Disorder |
2.5% |
| Hiv Infection |
2.3% |
| Oesophageal Carcinoma |
2.3% |
| Muscle Spasms |
2.2% |
| Premedication |
2.1% |
| Prophylaxis |
1.9% |
| Anxiety |
1.8% |
| Polyuria |
1.7% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Schizophrenia |
1.7% |
|
| Vomiting |
10.1% |
| Withdrawal Syndrome |
9.0% |
| Pulmonary Embolism |
7.9% |
| Weight Increased |
7.9% |
| Hospitalisation |
6.7% |
| Suicide Attempt |
6.7% |
| Drug Exposure During Pregnancy |
4.5% |
| Large Intestine Perforation |
4.5% |
| Tooth Loss |
4.5% |
| Urinary Tract Infection |
4.5% |
| Anal Abscess |
3.4% |
| Blood Bilirubin Increased |
3.4% |
| Cardiac Death |
3.4% |
| Febrile Neutropenia |
3.4% |
| Infection |
3.4% |
| Leukoencephalopathy |
3.4% |
| Neutropenic Sepsis |
3.4% |
| Oedema Peripheral |
3.4% |
| Pelvic Abscess |
3.4% |
| Pelvic Fracture |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
77.8% |
| Contraception |
11.1% |
| Pharyngitis |
11.1% |
|
| Maternal Exposure During Pregnancy |
100.0% |
|
